AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20843153 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A at 200,000 IU per day
Number of subjects: 67
Study 20843153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 18307921 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide sealer (Sealapex)
Number of subjects: 100
Study 18307921 — intervention group
Group type: COMPARATOR
Intervention: ZOE sealer
Number of subjects: 100
Study 16199742 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind smears
Number of subjects: 151
Study 16199742 — intervention group
Group type: COMPARATOR
Intervention: Guided smears
Number of subjects: 151
Study 14524141 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-oriented care intervention
Number of subjects: 151
Study 14524141 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 151
Study 11214781 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide (2.5 mg)
Number of subjects: 20
Study 11214781 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide (2.5 mg)
Number of subjects: 20
Study 11214781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8878758 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte induction (5 of 37 patients)
Number of subjects: 152
Study 8878758 — intervention group
Group type: COMPARATOR
Intervention: No antithymocyte induction (5 of 115 patients)
Number of subjects: 152
Study 8878758 — intervention group
Group type: EXPERIMENTAL
Intervention: More than two episodes of rejection during the first year after heart transplantation
Number of subjects: 152
Study 8878758 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole treatment
Number of subjects: 152
Study 1436435 — intervention group
Group type: EXPERIMENTAL
Intervention: Object velocity (four different velocities)
Number of subjects: 6
Study 1436435 — intervention group
Group type: COMPARATOR
Intervention: Control experiment with varying object velocity and size
Number of subjects: 6
Study 1436435 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed location for grasping with varying object velocity
Number of subjects: 6
Study 6496208 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath holding duration of 20 seconds
Number of subjects: 0
Study 6496208 — intervention group
Group type: COMPARATOR
Intervention: Breath holding duration of less than 20 seconds
Number of subjects: 0
Study 30933599 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit and vegetable vouchers only
Number of subjects: 0
Study 30933599 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly vouchers
Number of subjects: 0
Study 30933599 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted vouchers
Number of subjects: 0
Study 30933599 — intervention group
Group type: COMPARATOR
Intervention: Monthly vouchers
Number of subjects: 0
Study 27831697 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 59
Study 25857366 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin 420 mg daily in three divided doses starting 24‐48 h before cisplatin infusion and continuing through three 21‐day cisplatin chemotherapy courses
Number of subjects: 0
Study 25857366 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25110226 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glucose PD regimen (dextrose-based PD solution plus icodextrin and amino acids)
Number of subjects: 251
Study 25110226 — intervention group
Group type: COMPARATOR
Intervention: Conventional PD regimen (dextrose PD solutions)
Number of subjects: 251
Study 22479156 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 173
Study 22479156 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks of cART
Number of subjects: 173
Study 22479156 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 weeks of cART
Number of subjects: 173
Study 19008494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal (approximately 530 kcal; 100 g of carbohydrate, 1 g of fat, and 30 g of protein)
Number of subjects: 9
Study 19008494 — intervention group
Group type: COMPARATOR
Intervention: Control meal (approximately 800 kcal; 100 g of carbohydrate, 31 g of fat, and 30 g of protein)
Number of subjects: 9
Study 19008494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal plus lipid infusion (same meal as low-fat meal, total energy 800 kcal, with approximately 30 g fat via intravenous lipid infusion)
Number of subjects: 9
Study 19008494 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal
Number of subjects: 9
Study 19008494 — intervention group
Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 9
Study 17595937 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ketamine 0.5 mg/kg diluted with 0.9% saline
Number of subjects: 62
Study 17595937 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ketamine mixed with 0.125% bupivacaine 1 ml/kg
Number of subjects: 62
Study 17595937 — intervention group
Group type: COMPARATOR
Intervention: Plain 0.125% bupivacaine 1 ml/kg
Number of subjects: 62
Study 14998831 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Skills Training
Number of subjects: 39
Study 14998831 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Support
Number of subjects: 39
Study 14998831 — intervention group
Group type: EXPERIMENTAL
Intervention: Information
Number of subjects: 39
Study 11588451 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin (200 mg iv every 8 hrs)
Number of subjects: 80
Study 11588451 — intervention group
Group type: COMPARATOR
Intervention: Transpyloric feeding
Number of subjects: 80
Study 11588451 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin
Number of subjects: 80
Study 11588451 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric feeding with erythromycin and Transpyloric feeding
Number of subjects: 80
Study 9661589 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol levels from 10-25 pg/mL
Number of subjects: 274
Study 9661589 — intervention group
Group type: COMPARATOR
Intervention: Estradiol levels below 5 pg/mL
Number of subjects: 274
Study 9661589 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol levels exceeding 5 pg/mL
Number of subjects: 274
Study 8005183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg iv infusion
Number of subjects: 10
Study 8005183 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral solution
Number of subjects: 10
Study 8005183 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg standard tablet
Number of subjects: 10
Study 8005183 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg slow release formulation
Number of subjects: 10
Study 8005183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2523957 — intervention group
Group type: EXPERIMENTAL
Intervention: GR 38032F, 0.18 mg/kg, every six or every eight hours for three doses, beginning 30 minutes before cisplatin
Number of subjects: 85
Study 596252 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin and streptomycin
Number of subjects: 67
Study 596252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporin and gentamycin
Number of subjects: 67
Study 596252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporin and gentamycin with semi-isolation and granulocyte transfusions
Number of subjects: 67
Study 596252 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal sterilization with systemic antibiotics
Number of subjects: 67
Study 31285348 — intervention group
Group type: EXPERIMENTAL
Intervention: Giving motivational advice to younger students
Number of subjects: 1982
Study 31285348 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no advice given)
Number of subjects: 1982
Study 29064406 — intervention group
Group type: EXPERIMENTAL
Intervention: Diosgenin-rich yam extract for 12 weeks
Number of subjects: 28
Study 29064406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 26140415 — intervention group
Group type: EXPERIMENTAL
Intervention: Açai functional beverage (AB)
Number of subjects: 14
Study 26140415 — intervention group
Group type: COMPARATOR
Intervention: Control (without AB)
Number of subjects: 14
Study 25380005 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation of the efferent limb of the ileostomy before surgery
Number of subjects: 70
Study 25380005 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulation before surgery
Number of subjects: 70
Study 22456329 — intervention group
Group type: COMPARATOR
Intervention: TACE
Number of subjects: 95
Study 22456329 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-V (endostatin 15mg/m2 intravenously after TACE)
Number of subjects: 95
Study 22456329 — intervention group
Group type: EXPERIMENTAL
Intervention: TACE-A (endostatin 15mg/m2 through hepatic artery during TACE)
Number of subjects: 95
Study 22456329 — intervention group
Group type: COMPARATOR
Intervention: non-TACE
Number of subjects: 95
Study 19017893 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised asthma therapy
Number of subjects: 290
Study 17200487 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 0
Study 17200487 — intervention group
Group type: EXPERIMENTAL
Intervention: GPI-1485
Number of subjects: 0
Study 17200487 — intervention group
Group type: COMPARATOR
Intervention: Placebo (from DATATOP study)
Number of subjects: 0
Study 16462710 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose therapy
Number of subjects: 5
Study 16462710 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 5
Study 11455971 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A: 12 intensive parenteral treatments of intermediate dose (1 g/m2 each) methotrexate (MTX) and mercaptopurine (MP) over 24 weeks.
Number of subjects: 490
Study 11455971 — intervention group
Group type: COMPARATOR
Intervention: Regimen B: 12 intensive courses of alternating myelosuppressive drug combinations over 30 weeks, including MTX/MP, teniposide (VM-26)/cytosine arabinoside (AC), and VCR/PDN/DNR/AC/ASP.
Number of subjects: 490
Study 9724685 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐6‐PD‐deficient neonates with hyperbilirubinemia
Number of subjects: 2
Study 9724685 — intervention group
Group type: COMPARATOR
Intervention: G‐6‐PD‐deficient neonates without hyperbilirubinemia
Number of subjects: 2
Study 7508070 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 216
Study 7508070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 1378106 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroximone (0.5‐mg/kg bolus in 30 min and then 3‐6 micrograms/kg/min)
Number of subjects: 41
Study 1378106 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (1‐mg/kg bolus and then 4‐20 micrograms/kg/min)
Number of subjects: 41
Study 1378106 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (4‐10 micrograms/kg/min) and glyceroltrinitrate (0.5‐5 micrograms/kg/min)
Number of subjects: 41
Study 624224 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate (0.1 percent) aerosol
Number of subjects: 271
Study 30965131 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (315 μg/kg p.o.) during mindfulness retreat
Number of subjects: 38
Study 30965131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 38
Study 30965131 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study 28508427 — intervention group
Group type: EXPERIMENTAL
Intervention: IQP-CL-101 (two softgels twice daily before main meals)
Number of subjects: 99
Study 28508427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo twice daily before main meals)
Number of subjects: 99
Study 25453585 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/GSD patch (0.55 mg ethinyl estradiol and 2.1 mg gestodene)
Number of subjects: 346
Study 25453585 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptive (0.02 mg ethinyl estradiol and 0.1 mg levonorgestrel)
Number of subjects: 346
Study 23602084 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral load and CD4 cell count plus clinical monitoring (LAB)
Number of subjects: 385
Study 23602084 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strategy using LAB for patients starting ART with a CD4 count of 200 cells per μL or fewer
Number of subjects: 385
Study 23602084 — intervention group
Group type: COMPARATOR
Intervention: Clinical monitoring (CLIN)
Number of subjects: 385
Study 21801509 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-element acupuncture treatment
Number of subjects: 20
Study 19500889 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear carbohydrate drink (CCD) (400 ml, 50 g carbohydrate, 0 g protein)
Number of subjects: 20
Study 19500889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement (ONS400) (70 g, 50 g carbohydrate, 15 g glutamine dissolved in water to a total volume of 400 ml)
Number of subjects: 20
Study 19500889 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Nutritional Supplement (ONS300) (300 ml)
Number of subjects: 20
Study 17657595 — intervention group
Group type: EXPERIMENTAL
Intervention: Low quantities (2 g) of long chain lipid
Number of subjects: 16
Study 17657595 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium chain lipid (2 g)
Number of subjects: 16
Study 17657595 — intervention group
Group type: COMPARATOR
Intervention: Negative control formulation
Number of subjects: 16
Study 15118480 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/d) and Alprazolam (1 mg/d)
Number of subjects: 25
Study 15118480 — intervention group
Group type: COMPARATOR
Intervention: Alprazolam
Number of subjects: 25
Study 15118480 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine plus Alprazolam
Number of subjects: 25
Study 15118480 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychomotor Performance Tests and Visual Analogue Scales
Number of subjects: 25
Study 15118480 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 25
Study 10699767 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable biopsy forceps
Number of subjects: 0
Study 10699767 — intervention group
Group type: COMPARATOR
Intervention: Reusable biopsy forceps
Number of subjects: 0
Study 9181527 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin (1000 mg per day) and IFN-alpha (3-6 million units thrice weekly)
Number of subjects: 48
Study 9181527 — intervention group
Group type: COMPARATOR
Intervention: IFN-alpha alone
Number of subjects: 48
Study 8475971 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 0
Study 8475971 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 4039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbocisteine granulate (750 mg)
Number of subjects: 10
Study 4039146 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbocisteine capsules (750 mg)
Number of subjects: 10
Study 30810079 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish massage (SM)
Number of subjects: 11
Study 30810079 — intervention group
Group type: COMPARATOR
Intervention: Sham massage (ShM)
Number of subjects: 11
Study 29074816 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c alone
Number of subjects: 13538
Study 29074816 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting laboratory tests and clinic data
Number of subjects: 13538
Study 26896352 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-Wei-Qing-Yan aerosol (QWQYA) with the current propellant
Number of subjects: 420
Study 26896352 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-Wei-Qing-Yan aerosol (QWQYA) with a previous propellant
Number of subjects: 420
Study 26896352 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol with the current propellant
Number of subjects: 420
Study 26896352 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 420
Study 24967861 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc amino acid chelate
Number of subjects: 301
Study 24967861 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 301
Study 24967861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 22771576 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based screening and accrual method using Craigslist for recruitment
Number of subjects: 77
Study 21048706 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipeptidyl peptidase-4 (DPP-4) inhibitor
Number of subjects: 2
Study 21048706 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2
Study 21048706 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DPP-4 inhibitor and Metformin
Number of subjects: 2
Study 18372687 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily artificial gravity (AG) countermeasure treatment
Number of subjects: 15
Study 18372687 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AG treatment)
Number of subjects: 15
Study 16376764 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine bicycle stress exercise
Number of subjects: 18
Study 16376764 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright exercise treadmill testing
Number of subjects: 18
Study 16376764 — intervention group
Group type: COMPARATOR
Intervention: Comparison of peak exercise treadmill testing vs peak supine bicycle stress exercise
Number of subjects: 18
Study 11916892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed power head
Number of subjects: 6
Study 11916892 — intervention group
Group type: COMPARATOR
Intervention: Floating power head
Number of subjects: 6
Study 9453690 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375 mg of sustained-release hyoscyamine twice a day
Number of subjects: 34
Study 9453690 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg doxazosin QHS
Number of subjects: 34
Study 9453690 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (hyoscyamine and doxazosin)
Number of subjects: 34
Study 8575234 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 to 8 mg once daily
Number of subjects: 47
Study 8575234 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 25 to 62.5 mg twice daily
Number of subjects: 47
Study 2231185 — intervention group
Group type: EXPERIMENTAL
Intervention: Azidothymidine (AZT)
Number of subjects: 20
Study 2231185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 874420 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained spoken word
Number of subjects: 8
Study 874420 — intervention group
Group type: COMPARATOR
Intervention: Untrained spoken words
Number of subjects: 8
Study 31127269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (three doses of 200 mg iron sucrose over 30 min on three separate days)
Number of subjects: 80
Study 31127269 — intervention group
Group type: COMPARATOR
Intervention: Control (no intravenous iron)
Number of subjects: 80
Study 31127269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 80
Study 31127269 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 28939890 — intervention group
Group type: EXPERIMENTAL
Intervention: ELF-MF treatment for 45 minutes/day
Number of subjects: 6
Study 28939890 — intervention group
Group type: EXPERIMENTAL
Intervention: ELF-MF treatment for 120 minutes/day
Number of subjects: 6
Study 25469451 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracardiac echocardiography (ICE)
Number of subjects: 29
Study 25469451 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast anatomical mapping (FAM)
Number of subjects: 29
Study 25469451 — intervention group
Group type: COMPARATOR
Intervention: MSCT (gold standard)
Number of subjects: 29
Study 24968492 — intervention group
Group type: EXPERIMENTAL
Intervention: Bhastrika and Anulom Vilom Pranayam
Number of subjects: 96
Study 24968492 — intervention group
Group type: COMPARATOR
Intervention: Suryanamaskar
Number of subjects: 96
Study 21426543 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF) with volar locked plating
Number of subjects: 504
Study 21426543 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and plaster casting
Number of subjects: 504
Study 19290712 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical cancer preventive treatment with one or two small side effects (beneficial or harmful)
Number of subjects: 5379
Study 19290712 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of side effects (beneficial or harmful)
Number of subjects: 5379
Study 19290712 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 5379
Study 17235521 — intervention group
Group type: EXPERIMENTAL
Intervention: dTpa-IPV (Boostrix Polio)
Number of subjects: 958
Study 17235521 — intervention group
Group type: COMPARATOR
Intervention: dTpa + IPV (Boostrix + IPV Mérieux)
Number of subjects: 958
Study 15655328 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line HDF
Number of subjects: 0
Study 15655328 — intervention group
Group type: EXPERIMENTAL
Intervention: HDF (post, pre)
Number of subjects: 0
Study 15655328 — intervention group
Group type: COMPARATOR
Intervention: HD
Number of subjects: 0
Study 15655328 — intervention group
Group type: EXPERIMENTAL
Intervention: HDF
Number of subjects: 0
Study 11678958 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of tacrolimus after an overnight fast
Number of subjects: 33
Study 11678958 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of tacrolimus 1 hour after breakfast
Number of subjects: 33
Study 11678958 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of tacrolimus after an overnight fast and 0.5 hours after breakfast (in 4 patients)
Number of subjects: 33
Study 11678958 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who underwent continuous ambulatory peritoneal dialysis (CAPD) before transplantation
Number of subjects: 33
Study 9039169 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment
Number of subjects: 77
Study 9039169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 7686471 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 42
Study 7686471 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ethanol (LD)
Number of subjects: 42